Student electives for Gina Hadley, Clare Webb, Zoeb Jiwaji, Emily Parker and Jonarthan Thevanayagam. (360G-Wellcome-083630_Z_07_Z)

£5,600

Malaria is one of the deadliest infectious parasitic diseases. Combination therapy, which has already been introduced in Kenya may not address the problem of the ability of the parasite to quickly select for resistance against antimalarial drugs, due to the detrimental effect of disparate pharmacokinetic profiles of drugs used. Strategies have to be devised to tackle the drug resistance. One such strategy is to predict and monitor the emergence and the spread of drug resistance parasite before drug resistance become s a problem. As Co-artem® has already been introduced in Kenya, the information that this project will provide is vital.

Where is this data from?

This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.

Grant Details

Amount Awarded 5600
Applicant Surname Lancaster
Approval Committee Neurosciences And Mental Health
Award Date 2007-07-18T00:00:00+00:00
Financial Year 2006/07
Grant Programme: Title Studentship: Inactive scheme
Internal ID 083630/Z/07/Z
Lead Applicant Dr Tim Lancaster
Partnership Value 5600
Planned Dates: End Date 2008-08-10T00:00:00+00:00
Planned Dates: Start Date 2007-07-11T00:00:00+00:00
Recipient Org: Country United Kingdom
Region South East